Metelimumab (CAT-192) is a human IgG4 monoclonal antibody engineered to selectively neutralize transforming growth factor beta 1 (TGF??1). This specificity makes it a valuable tool for researchers studying fibrosis, cancer progression, and other TGF??1-related pathologies.
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody engineered to selectively neutralize transforming growth factor beta 1 (TGF??1). This specificity makes it a valuable tool for researchers studying fibrosis, cancer progression, and other TGF??1-related pathologies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: